Skip to main content
Log in

Macrofollicular variant of papillary thyroid carcinoma: A case and control analysis

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript


The planimetric, flow cytometric, and immunohistochemical characteristics of the macrofollicular variant of papillary thyroid carcinoma (MFVPTC) have not been reported before. The clinical, morphological, immunohistochemical, planimetric, and flow cytometric characteristics of six cases of the MFVPTC and six of the follicular variant of papillary thyroid carcinoma (FVPTC) were analyzed. Patients had undergone surgical treatment. The mean age was 38 (range 29–64 yr), and five were women. Tumors had a mean size of 3.2 cm (range 0.3–4.5 cm). Half were originally diagnosed as goiter. Macrofollicles had a mean diameter of 345.5 μm, perimeter of 1237 μm, and area of 13,779 μm2, with nuclear changes of PTC. Mean follow-up was 107 mo (range 12–277), and neither lymph node metastases nor recurrence were seen. Differences in diameter, perimeter, and area between the macrofollicular and follicular variants were found. Follicular neoplastic cells were thyroglobulin and S-100 protein positive in macrofollicles and normofollicles. All were negative to cytokeratin and to high-mol-wt keratin. All tumors were diploid. There were no significant differences in follow-up, DNA content, nor immunohistochemical reactivity. Differences in diameter (p<0.00006), perimeter (p<0.0001), and area (p<0.001) were observed. It is important to recognize this variant because it could be misdiagnosed as benign thyroidal lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 12:22–27, 1988.

    CAS  PubMed  Google Scholar 

  2. Evans HL. Columnar cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 85:77–80, 1986.

    CAS  PubMed  Google Scholar 

  3. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041–1049, 1989.

    CAS  PubMed  Google Scholar 

  4. Albores-Saavedra J, Gould E, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma. A study of 17 cases. Hum Pathol 22:1195–1205, 1991.

    Article  CAS  PubMed  Google Scholar 

  5. Schröder S, Böcker W, Dralle H, Kortmann K, Stern C. The encapsulated papillary carcinoma of the thyroid. A morphologic subtype of the papillary thyroid carcinoma. Cancer 54:90–93, 1984.

    Article  PubMed  Google Scholar 

  6. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–828, 1985.

    Article  CAS  PubMed  Google Scholar 

  7. Chen KTK, Rosai J. Follicular variant of thyroid papillary carcinoma. A clinicopathologic study of six cases. Am J Surg Pathol 1:123–130, 1977.

    Article  Google Scholar 

  8. Silverberg E, Lubera J. Cancer statistics. CA 36:9–25, 1986.

    Article  CAS  PubMed  Google Scholar 

  9. Sierra M, Herrera MF, Angeles-Angeles A, Gamboa-Dominguez A. Carcinoma anaplásico de glándula tiroides. Incidencia, enfermedades tiroideas asociadas y evolución en un centro de referencia. Patologia (México) 33:S21, 1995.

    Google Scholar 

  10. Rodríguez-Cuevas S, Labastida S, Reyes JM, Rodríguez E. Papillary thyroid carcinoma in Mexico: review of 409 cases. Head Neck 5:537–545, 1993.

    Article  Google Scholar 

  11. Herrera MF, López-Graniel CM, Saldaña J, Gamboa-Domínguez A, Richaud-Patín Y, Vargas-Vorackova F, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg 20:94–100, 1996.

    Article  CAS  PubMed  Google Scholar 

  12. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Sem Oncol 14:315–332, 1987.

    CAS  Google Scholar 

  13. Ambros RA, Trost RC, Campbell AY, Lambert WC. Prognostic value of morphometry in papillary thyroid carcinoma. Hum Pathol 20:215–218, 1989.

    Article  CAS  PubMed  Google Scholar 

  14. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1976: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978–996, 1986.

    CAS  PubMed  Google Scholar 

  15. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. 3rd ser. Washington, DC. Armed Forces Institute of Pathology, 1992.

    Google Scholar 

  16. Hoda SA, Reed RJ. S-100 protein immunoreactivity differentiates follicular from papillary neoplasms of thyroid. Lab Invest 68:38A, 1993.

    Google Scholar 

  17. Sierra-Salazar M, Candanedo-González F, Barredo BA, Gambo-Domínguez A. Utilidad de proteína S-100 en lesiones tiroideas. Patología (México) 34:S35, 1996.

    Google Scholar 

  18. Joensuu H, Klemi P, Eerola E, Tuominen J. Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer 58:2462–2467, 1989.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Armando Gamboa-Domínguez MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gamboa-Domínguez, A., Vieitez-Martínez, I., Barredo-Prieto, B.A. et al. Macrofollicular variant of papillary thyroid carcinoma: A case and control analysis. Endocr Pathol 7, 303–308 (1996).

Download citation

  • Issue Date:

  • DOI:

Key Words